Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
Guosen: Optimistic about the automotive sector entering a period of bullish trends. In the medium to long term, optimistic about opportunities for going global and upgrading the industry.
Citigroup: Downgrade Q TECH (01478) target price to HK$9, downgraded rating to "Neutral"
HK Stock Market Move | Knowledge Atlas (02513) rose more than 5%, released GLM-5-Turbo and raised API prices. CICC raised target price to 800 Hong Kong dollars.
Guosen: Optimistic about the automotive sector entering a period of bullish trends. In the medium to long term, optimistic about opportunities for going global and upgrading the industry.
Citigroup: Downgrade Q TECH (01478) target price to HK$9, downgraded rating to "Neutral"
HK Stock Market Move | Knowledge Atlas (02513) rose more than 5%, released GLM-5-Turbo and raised API prices. CICC raised target price to 800 Hong Kong dollars.
